glp-1 brand Medications for Weight Loss 1 supplement supports weight management. Conagra Brands eyes GLP-1 users

Retatrutide achieved up to 24.2% mean weight loss after 48 weeks in individuals with obesity and 16.9% in those with T2D after 36 weeks

Often used in longevity and wellness protocols, Sermorelin offers a lower-risk alternative to direct GH therapy and is typically well tolerated over long-term use

The compound is not a supplement, cosmetic or therapeutic substance and any misuse outside of research applications is against regulatory guidelines and institutional policies

This brief highlights how the financialized business model perpetuates health inequities that will disproportionately impact Black Americans and other marginalized populations who face higher rates of obesity and diabetes yet remain underrepresented in access to GLP-1 therapies

Curr Obes Rep 12 , 6174 (2023)